Very low energy ketogenic therapy + liraglutide
Very low energy ketogenic therapy + liraglutide has been studied in 1 paper since 2025: 1 trial in people. The newest paper, Oct 22, 2025: “SUN-675 Very Low Energy Ketogenic Therapy In Combination With Liraglutide As A Synergic Strategy For The Treatment Of Obesity: A Real-world Clinical Evaluation”.
1 paper studies it4 findingsUpdated
See all 1 papers on very low energy ketogenic therapy + liraglutide
At a glance
The findings reach people, from one lab or study. 1 lab in 1 country.
“However, the VLEKT +Lira group experienced greater weight loss (-20.4% vs -14.7%, p = 0.013)”
None of its findings points the other way.
- 1 lab in 1 country
- Human trial1
Studies in people
1 study gave very low energy ketogenic therapy + liraglutide to people and measured what changed.
| What changed | Design | People | Source |
|---|---|---|---|
down: Decreases body weight-20.4% vs -14.7%, p = 0.013 down: Decreases insulin resistancep<0.001 up: Increases ketone | Treated cohortfour-month | Patient cohorts | ENDO 2025 abstract, Oct 22, 2025 |
What did studies of very low energy ketogenic therapy + liraglutide find?
4Studies of very low energy ketogenic therapy + liraglutide measured 4 outcomes, among them nausea, ketone and insulin resistance.
Nausea
upin humans1
1 study
Nausea
upin humans1
Very low energy ketogenic therapy + liraglutide is linked with higher nausea in humans (p<0.001).
“Despite the metabolic benefits, the VLEKT +Lira group reported a higher incidence of adverse effects, including nausea (p<0.001), heartburn (0.004), reflux (p=0.009)”
Humansfour-month
ENDO 2025 abstract
Ketone
upin humans1
1 study
Ketone
upin humans1
Very low energy ketogenic therapy + liraglutide is linked with higher ketone in humans.
“Ketone levels were higher in the combination group, suggesting improved adherence to the dietary regimen.”
Humansfour-month
ENDO 2025 abstract
Insulin resistance
downin humans1
1 study
Insulin resistance
downin humans1
Very low energy ketogenic therapy + liraglutide is linked with lower insulin resistance in humans (p<0.001).
“and a more pronounced reduction in insulin resistance (p<0.001).”
Humansfour-month
ENDO 2025 abstract
Body weight
downin humans1
1 study
Body weight
downin humans1
Very low energy ketogenic therapy + liraglutide is linked with lower body weight in humans (-20.4% vs -14.7%, p = 0.013).
“However, the VLEKT +Lira group experienced greater weight loss (-20.4% vs -14.7%, p = 0.013)”
Humansfour-month
ENDO 2025 abstract